1. Home
  2. VCEL vs MMS Comparison

VCEL vs MMS Comparison

Compare VCEL & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$40.38

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$91.41

Market Cap

4.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
MMS
Founded
1989
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
4.7B
IPO Year
1997
1997

Fundamental Metrics

Financial Performance
Metric
VCEL
MMS
Price
$40.38
$91.41
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$57.50
$90.00
AVG Volume (30 Days)
591.3K
631.8K
Earning Date
02-26-2026
02-05-2026
Dividend Yield
N/A
1.35%
EPS Growth
236.54
10.42
EPS
0.25
5.51
Revenue
$258,716,999.00
$5,431,276,000.00
Revenue This Year
$17.86
$1.71
Revenue Next Year
$18.55
$4.98
P/E Ratio
$159.52
$16.17
Revenue Growth
14.05
2.36
52 Week Low
$29.24
$63.77
52 Week High
$63.00
$92.50

Technical Indicators

Market Signals
Indicator
VCEL
MMS
Relative Strength Index (RSI) 63.46 67.02
Support Level $35.33 $85.78
Resistance Level $38.15 $91.09
Average True Range (ATR) 1.42 2.00
MACD 0.32 0.31
Stochastic Oscillator 84.25 82.77

Price Performance

Historical Comparison
VCEL
MMS

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: